News & Supplemental  

New documents show the monkey virus is present in more recent polio vaccine

by William Carlsen
San Fran­cisco Chronicle

A mon­key virus linked to human can­cers may have con­t­a­m­i­nated the oral polio vac­cine for years after the U.S. gov­ern­ment ordered man­u­fac­tur­ers to remove it, accord­ing to drug com­pany doc­u­ments obtained by The Chronicle.

The Chron­i­cle reported last week that the simian virus SV40 had con­t­a­m­i­nated early polio vac­cine given to mil­lions of Amer­i­cans. When health offi­cials dis­cov­ered in 1961 that SV40 caused malig­nant tumors in lab ani­mals, they ordered the virus elim­i­nated from all future vaccine.

But inter­nal memos from Led­erle Lab­o­ra­to­ries, the chief pro­ducer of polio vac­cine in the United States, indi­cate SV40 may not have been com­pletely removed.

Accord­ing to one memo, SV40 was found in three of 15 lots of the oral vac­cine seven months after the fed­eral direc­tive was issued in March 1961. Led­erle released the con­t­a­m­i­nated vac­cine to the pub­lic any­way, the memo shows.

The doc­u­ments also sug­gest that the com­pany failed to test the mon­key– kid­ney seed strains used to make the bulk polio vac­cine for con­t­a­m­i­na­tion, despite a writ­ten warn­ing from Dr. Albert Sabin, who devel­oped the oral vaccine.

Led­erle and the U.S. gov­ern­ment insist there is no evi­dence that any con­t­a­m­i­nated vac­cine was dis­trib­uted after the direc­tive went into effect.

Sci­en­tists dis­cov­ered SV40 in the Salk polio vac­cine in 1960. By then as many as 30 mil­lion Amer­i­cans had been given injec­tions of the SV40-tainted polio vac­cine, which was first licensed in 1955.

In recent years more than 60 sci­en­tific stud­ies have found SV40 in rare human brain, bone and lung-related can­cers, the same kinds of tumors the virus caused in lab­o­ra­tory ani­mals. Some sci­en­tists believe SV40 may play a role in caus­ing those cancers.

One of the biggest mys­ter­ies, how­ever, is why SV40 has been found in tumors removed from peo­ple who never received the con­t­a­m­i­nated Salk vaccine.

Researchers have sev­eral the­o­ries for how the virus could have spread from those infected through the Salk vac­cine: in trans­mis­sion from mother to fetus or through breast milk; through sex­ual activ­ity or a flu-like virus.

But the Led­erle doc­u­ments, which were obtained by Philadel­phia attor­ney Stan­ley Kops in lit­i­ga­tion not related to SV40, raise the pos­si­bil­ity the virus might have been trans­mit­ted by con­t­a­m­i­nated oral vac­cine, licensed for pro­duc­tion in 1962.

The doc­u­ments include:

– A Novem­ber 1961 memo say­ing the virus was found in three of 15 lots of vac­cine. Accord­ing to the memo, Dr. Rod­er­ick Mur­ray, head of the government’s pro­gram to ensure vac­cine purity, allowed the lots to be released.

To com­ply with the removal order, Led­erle had switched from rhe­sus mon­keys, which are nat­ural hosts for SV40, to African green mon­keys, sup­pos­edly free from SV40. How­ever, the memo notes that SV40 was found in 10 per­cent of the green monkeys.

– A let­ter from Sabin to Led­erle in Octo­ber 1962, warn­ing that suf­fi­cient test­ing for SV40 con­t­a­m­i­na­tion had not been done on one of his strains of weak­ened polio virus that formed the seed for bulk vac­cine production.

– A con­fi­den­tial memo in 1979 from a Led­erle offi­cial stat­ing: “It should be noted that Led­erle did not test the orig­i­nal Sabin seeds for extra­ne­ous agents or neu­rovir­u­lence since Dr. Sabin assured us that this had been done.”

– Another memo stat­ing that Led­erle did not test the seed “since only 50 (mil­li­liters) or less of each seed were pro­vided by Dr. Sabin.”

The two memos added that test­ing was unnec­es­sary because later vac­cine sam­ples sub­mit­ted for license were free of SV40.

Kops also said that he had taken tes­ti­mony in 1998 from a top Led­erle offi­cial who said the com­pany did not have the test results from many of the vac­cine lots.

“The vac­cine man­u­fac­tur­ers and the gov­ern­ment need to dis­close what really hap­pened,” said Kops. “With­out the facts, (sci­en­tists) will con­tinue to look in the wrong places to explain how peo­ple were infected with SV40 after 1961.”

Led­erle did not respond to requests for comment.

At a 1997 con­fer­ence, how­ever, a com­pany rep­re­sen­ta­tive out­lined the series of tests the com­pany uses to detect SV40 con­t­a­m­i­na­tion. The com­pany also says that it uses anti­serum to neu­tral­ize any SV40 in the “mas­ter seeds.”

But it is not clear whether these pro­ce­dures were in place in the years after the U.S. gov­ern­ment issued its directive.

Last year, a law­suit was filed in Los Ange­les against Led­erle by the par­ents of 2 1/2-year-old Alexan­der Hor­win who died of a brain tumor that later tested pos­i­tive for SV40. The suit claims that the tumor was caused by SV40 and that he became infected through a 1997 oral polio vaccine.

Kops and attor­ney Don­ald MacLach­lan rep­re­sent a New Jer­sey fam­ily that is con­sid­er­ing a suit against vac­cine manufacturers.

In 1970, sur­geons removed a large brain tumor from 2-year-old Mark Moreno. He since has under­gone five more surg­eries and now wears a pro­tec­tive hel­met over the large open­ing in his cra­nium where bone grafts never took. Moreno, now 33, lives with his mother and requires daily assistance.

Recent tests show Moreno’s tumor was rid­dled with SV40, accord­ing to the lawyers.

Eileen Moreno, Mark’s mother, believes her son’s brain tumor was caused by SV40 and that he was infected through the oral polio vac­cine in 1968.

Last year, two inves­ti­ga­tors from the U.S. Food and Drug Admin­is­tra­tion used genetic test­ing to exam­ine 30 sam­ples of bulk oral polio vac­cine used in the United States going back to 1972. They reported find­ing no SV40.

But the gov­ern­ment has not used the genetic tests to deter­mine whether vac­cine made prior to 1972 was contaminated.

Dr. William Egan, deputy direc­tor of the FDA’s vac­cine research branch, said test­ing went back only to 1972 because those sam­ples were the only ones avail­able to them. “There was noth­ing sin­is­ter,” he said.

MacLach­lan said he finds it “incred­i­ble” that the gov­ern­ment hasn’t com­pre­hen­sively inves­ti­gated the pos­si­bil­ity of SV40 con­t­a­m­i­na­tion of the oral vac­cine.
Simian virus Q&A Q: How wide­spread is the SV40 infection?

A: Sci­en­tists and gov­ern­ment health offi­cials don’t know, because no com­pre­hen­sive stud­ies have addressed the ques­tion. What is known is that dur­ing the 1950s and ‘60s, at least 10 mil­lion to 30 mil­lion Amer­i­cans — and more than 100 mil­lion peo­ple world­wide — were given SV40-contaminated polio vac­cine. The virus also has been found in peo­ple who did not receive con­t­a­m­i­nated vaccine.

Q: Can I be tested for SV40?

A: An accu­rate blood test does not exist. Cur­rent anti­body blood tests can be inac­cu­rate, sci­en­tists say, because they also may detect the pres­ence of closely related viruses, and SV40 may be present at such a low level that no anti­bod­ies are pro­duced. Researchers are work­ing to cre­ate an effec­tive test.

Q: In which kinds of can­cers has SV40 been found?

A: The virus has been detected in rare can­cers, including:

– Mesothe­lioma, a fatal tumor of the mem­brane sur­round­ing the lungs. Few cases were reported prior to 1950, but the inci­dence has grown in the United States to 2,000 to 4,000 cases a year, with greater inci­dence in Europe.

– Brain can­cers: Pri­mar­ily ependy­mo­mas and choroid plexus tumors, but also astro­cy­tomas, glioblas­tomas, medul­loblas­toma, and menin­giomas. Fewer than 1, 000 cases of these can­cers are reported in the United States each year.

– Bone can­cers: Pri­mar­ily osteosar­co­mas, but also chon­drosar­coma and giant cell tumors. These also make up fewer than 1,000 cases annually.

Discussion

No comments for “New documents show the monkey virus is present in more recent polio vaccine”

Post a comment

Recommended Reading

The Splendid Blond Beast Money, Law, and Genocide in the Twentieth Century, by Christopher... Read more »